Skip to main content
Top
Published in: Annals of Hematology 9/2016

01-09-2016 | Letter to the Editor

Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms

Authors: Luisa Anelli, Antonella Zagaria, Nicoletta Coccaro, Giuseppina Tota, Angela Minervini, Paola Casieri, Luciana Impera, Crescenzio Francesco Minervini, Claudia Brunetti, Alessandra Ricco, Paola Orsini, Cosimo Cumbo, Giorgina Specchia, Francesco Albano

Published in: Annals of Hematology | Issue 9/2016

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
go back to reference Nangalia J, Massie CE, Baxter EJ et al (2013) Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 369:2391–2405CrossRefPubMedPubMedCentral Nangalia J, Massie CE, Baxter EJ et al (2013) Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med 369:2391–2405CrossRefPubMedPubMedCentral
2.
go back to reference Klampfl T, Gisslinger H, Harutyunyan AS et al (2013) Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 369:2379–2390CrossRefPubMed Klampfl T, Gisslinger H, Harutyunyan AS et al (2013) Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 369:2379–2390CrossRefPubMed
3.
go back to reference Jones AV, Ward D, Lyon M et al (2015) Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms. Leuk Res 39:82–87CrossRefPubMed Jones AV, Ward D, Lyon M et al (2015) Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms. Leuk Res 39:82–87CrossRefPubMed
4.
go back to reference Chi J, Manoloukos M, Pierides C et al (2015) Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring. Ann Hematol 94:399–408CrossRefPubMed Chi J, Manoloukos M, Pierides C et al (2015) Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring. Ann Hematol 94:399–408CrossRefPubMed
5.
go back to reference Albano F, Zagaria A, Anelli L et al (2015) Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. Oncotarget 6:13269–13277CrossRefPubMedPubMedCentral Albano F, Zagaria A, Anelli L et al (2015) Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia. Oncotarget 6:13269–13277CrossRefPubMedPubMedCentral
6.
go back to reference Drandi D, Kubiczkova-Besse L, Ferrero S et al (2015) Minimal residual disease detection by droplet digital PCR in multiple myeloma, mantle cell lymphoma, and follicular lymphoma: a comparison with real-time PCR. J Mol Diagn 17:652–660CrossRefPubMed Drandi D, Kubiczkova-Besse L, Ferrero S et al (2015) Minimal residual disease detection by droplet digital PCR in multiple myeloma, mantle cell lymphoma, and follicular lymphoma: a comparison with real-time PCR. J Mol Diagn 17:652–660CrossRefPubMed
7.
go back to reference Zagaria A, Anelli L, Coccaro N et al (2015) BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR. Virchows Arch 467:357–363CrossRefPubMed Zagaria A, Anelli L, Coccaro N et al (2015) BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR. Virchows Arch 467:357–363CrossRefPubMed
8.
go back to reference Mansier O, Migeon M, Saint-Lézer A et al (2016) Quantification of the mutant CALR allelic burden by digital PCR: application to minimal residual disease evaluation after bone marrow transplantation. J Mol Diagn 18:68–74CrossRefPubMed Mansier O, Migeon M, Saint-Lézer A et al (2016) Quantification of the mutant CALR allelic burden by digital PCR: application to minimal residual disease evaluation after bone marrow transplantation. J Mol Diagn 18:68–74CrossRefPubMed
9.
go back to reference Badbaran A, Fehse B, Christopeit M et al (2016) Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation. Bone Marrow Transplant 51(6):872–873CrossRefPubMed Badbaran A, Fehse B, Christopeit M et al (2016) Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation. Bone Marrow Transplant 51(6):872–873CrossRefPubMed
10.
go back to reference Cassinat B, Verger E, Kiladjian JJ (2014) Interferon alfa therapy in CALR-mutated essential thrombocythemia. N Engl J Med 371:188–189CrossRefPubMed Cassinat B, Verger E, Kiladjian JJ (2014) Interferon alfa therapy in CALR-mutated essential thrombocythemia. N Engl J Med 371:188–189CrossRefPubMed
Metadata
Title
Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms
Authors
Luisa Anelli
Antonella Zagaria
Nicoletta Coccaro
Giuseppina Tota
Angela Minervini
Paola Casieri
Luciana Impera
Crescenzio Francesco Minervini
Claudia Brunetti
Alessandra Ricco
Paola Orsini
Cosimo Cumbo
Giorgina Specchia
Francesco Albano
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 9/2016
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-016-2739-2

Other articles of this Issue 9/2016

Annals of Hematology 9/2016 Go to the issue